The Pediatric Low-Grade Glioma Externally-Led Patient-Focused Drug Development Meeting is an important opportunity for pediatric low-grade glioma patients, survivors, their families, and caregivers to speak directly to the FDA, pharmaceutical companies, and public about their current and past experiences with pLGG and the impact the disease has had on their daily lives.
Friday, February 23, 2024
10 a.m. – 3 p.m. ET
This virtual meeting is free to attend and a recording will be available after the meeting.
If you would like to attend, please fill out the form below.